 |
PDBsum entry 6bsd
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Transferase/transferase inhibitor
|
PDB id
|
|
|
|
6bsd
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
What makes a kinase promiscuous for inhibitors?
|
 |
|
Authors
|
 |
S.M.Hanson,
G.Georghiou,
M.K.Thakur,
W.T.Miller,
J.S.Rest,
J.D.Chodera,
M.A.Seeliger.
|
 |
|
Ref.
|
 |
Cell Chem Biol, 2019,
26,
390.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
|
|
 |
 |
|
Abstract
|
 |
|
ATP-competitive kinase inhibitors often bind several kinases due to the high
conservation of the ATP binding pocket. Through clustering analysis of a large
kinome profiling dataset, we found a cluster of eight promiscuous kinases that
on average bind more thanĀ five times more kinase inhibitors than the other 398
kinases in the dataset. To understand the structural basis of promiscuous
inhibitor binding, we determined the co-crystal structure of the receptor
tyrosine kinase DDR1 with the type I inhibitors dasatinib and VX-680.
Surprisingly, we find that DDR1 binds these type I inhibitors in an inactive
conformation typically reserved for type II inhibitors. Our computational and
biochemical studies show that DDR1 is unusually stable in this inactive
conformation, giving a mechanistic explanation for inhibitor promiscuity. This
phenotypic clustering analysis provides a strategy to obtain functional insights
not available by sequence comparison alone.
|
 |
|
|
|
|
 |